These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3274476)

  • 41. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term residual cyclosporine levels following short-term administration in various allograft models demonstrating extensive survival prolongation.
    Hewitt CW; Black KS; Gonzalez GA; Dowdy SF; Reyes M; Martin DC; Achauer BM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1244-5. PubMed ID: 3274310
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term protective effect of a calcium antagonist on renal function in hypertensive renal transplant patients on cyclosporine therapy: a 5-year prospective randomized study.
    Morales JM; Rodriguez-Paternina E; Araque A; Andres A; Hernandez E; Ruilope LM; Rodicio JL
    Transplant Proc; 1994 Oct; 26(5):2598-9. PubMed ID: 7940807
    [No Abstract]   [Full Text] [Related]  

  • 45. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
    Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
    Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine monotherapy--an ideal long-term immunosuppression?
    Schleibner S; Schneeberger H; Hillebrand G; Illner WD; Krumme D; Roed M; Land W
    Transplant Proc; 1990 Aug; 22(4):1695-6. PubMed ID: 2389435
    [No Abstract]   [Full Text] [Related]  

  • 47. Kidney retransplantation in the cyclosporine era.
    Stratta RJ; Oh CS; Sollinger HW; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):40-5. PubMed ID: 3276060
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of immunological risk factors on the outcome of cadaveric renal transplantation as revealed in transplants with primary graft anuria.
    Madsen M; Fjeldborg O; Rasmussen A; Povlsen JV; Kissmeyer-Nielsen F
    Transplant Proc; 1990 Aug; 22(4):1371-2. PubMed ID: 2389332
    [No Abstract]   [Full Text] [Related]  

  • 49. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of the optimal donor quality scoring system and measure of early renal function in kidney transplantation.
    Moore J; Ramakrishna S; Tan K; Cockwell P; Eardley K; Little MA; Rylance P; Shivakumar K; Suresh V; Tomlinson K; Ready A; Borrows R
    Transplantation; 2009 Feb; 87(4):578-86. PubMed ID: 19307797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Impact of allograft weight and the recipient's body weight on long-term allograft function].
    Fu SJ; Yu LX; DU CF; Xu J; Liu XY; Wang YB
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1295-6. PubMed ID: 15567784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of donor/recipient body weight mismatch on allograft outcome in renal transplant recipients.
    Ghafari A; Etemadi J; Ardalan M
    Transplant Proc; 2008; 40(1):135-6. PubMed ID: 18261568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early and late complications of cyclosporine treatment in a 5-year follow-up of 250 renal transplant recipients.
    Civati G; Busnach G; Perrino ML; Broggi ML; Brando B; Seveso M; Minetti L
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1571-2. PubMed ID: 2652510
    [No Abstract]   [Full Text] [Related]  

  • 56. An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients.
    Salomon DR
    Transplant Proc; 1991 Aug; 23(4):2115-8. PubMed ID: 1871827
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term improvement of chronic renal graft dysfunction in cyclosporine-treated patients by addition of azathioprine and reduction of cyclosporine.
    Kliem V; Repp H; Frei U
    Transplant Proc; 1994 Oct; 26(5):2553-5. PubMed ID: 7940788
    [No Abstract]   [Full Text] [Related]  

  • 58. Preemptive living-donor renal transplantation: outcome and clinical advantages.
    Yoo SW; Kwon OJ; Kang CM
    Transplant Proc; 2009; 41(1):117-20. PubMed ID: 19249492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Similar impact of slow and delayed graft function on renal allograft outcome and function.
    Rodrigo E; Fernández-Fresnedo G; Ruiz JC; Piñera C; Palomar R; González-Cotorruelo J; Zubimendi JA; De Francisco AL; Sanz de Castro S; Arias M
    Transplant Proc; 2005 Apr; 37(3):1431-2. PubMed ID: 15866627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.